Soligenix (SNGX) EBITDA Margin Growth (5y) (2015 - 2024)
Soligenix (SNGX) EBITDA Margin Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.43 Mn |
| Mar 31, 2024 | -160,812.00 |
| Dec 31, 2023 | -56,217.00 |
| Sep 30, 2023 | -122,500.00 |
| Jun 30, 2023 | -69,576.00 |
| Mar 31, 2023 | -62,246.00 |
| Dec 31, 2022 | -72,632.00 |
| Sep 30, 2022 | -180,139.00 |
| Jun 30, 2022 | -125,120.00 |
| Mar 31, 2022 | -209,864.00 |
| Dec 31, 2021 | -156,051.00 |
| Sep 30, 2021 | -175,652.00 |
| Jun 30, 2021 | -135,925.00 |
| Mar 31, 2021 | -144,092.00 |
| Sep 30, 2020 | -26,503.00 |
| Jun 30, 2020 | 1.09 Mn |
| Mar 31, 2020 | 58,353.00 |
| Dec 31, 2019 | -9,598.00 |
| Sep 30, 2019 | -10,772.00 |
| Jun 30, 2019 | -8,449.00 |